About Modulim
Modulim is a company based in Irvine (United States) founded in 2002 by David Cuccia.. Modulim has raised $12.36 million across 16 funding rounds from investors including NIH, Fresenius Medical Care and HHS. Modulim offers products and services including Imaging Solutions and Data Solutions. Modulim operates in a competitive market with competitors including Mimosa Diagnostics, OxiLight, O’Brien Medical, Medical Monofilament and Innovative Wellness Systems, among others.
- Headquarter Irvine, United States
- Founders David Cuccia
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Modulated Imaging Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$12.36 M (USD)
in 16 rounds
-
Latest Funding Round
$7 M (USD), Series B
Dec 20, 2018
-
Investors
NIH
& 9 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Modulim
Modulim offers a comprehensive portfolio of products and services, including Imaging Solutions and Data Solutions. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Provides tools for assessing lower limb health through microvascular data.
Offers insights to manage complications from diabetes and related diseases.
Unlock access to complete
Electrical Team
1 people
Leadership Team
1 people
Founder Team
1 people
Software Development Team
1 people
Unlock access to complete
Funding Insights of Modulim
Modulim has successfully raised a total of $12.36M across 16 strategic funding rounds. The most recent funding activity was a Series B round of $7 million completed in December 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 16
- Last Round Series B — $7.0M
-
First Round
First Round
(19 Sep 2006)
- Investors Count 10
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec, 2018 | Amount | Series B - Modulim | Valuation | Pangaea Ventures | |
| Nov, 2017 | Amount | Grant - Modulim | Valuation |
investors |
|
| Nov, 2017 | Amount | Series A - Modulim | Valuation | Grey Sky Venture Partners |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Modulim
Modulim has secured backing from 10 investors, including venture fund and institutional investors. Prominent investors backing the company include NIH, Fresenius Medical Care and HHS. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investment in hard tech for planetary health, focusing on materials science, chemistry, and biology.
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location | |
|
Venture capital is invested in AI, energy, and various sectors.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Modulim
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Modulim
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Modulim Comparisons
Competitors of Modulim
Modulim operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Mimosa Diagnostics, OxiLight, O’Brien Medical, Medical Monofilament and Innovative Wellness Systems, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Early foot ulcer detection is facilitated by non-invasive mHealth technology.
|
|
| domain | founded_year | HQ Location |
Wound imaging solutions for diabetic foot ulcers and peripheral vascular disease
|
|
| domain | founded_year | HQ Location |
Medical devices for neuropathy diagnosis and monitoring are developed.
|
|
| domain | founded_year | HQ Location |
Manufactures sensory testing monofilaments to aid diabetic foot care and prevention.
|
|
| domain | founded_year | HQ Location |
Produces high-quality biomechanical footwear for diabetic foot ulcer care and analysis.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Modulim
Frequently Asked Questions about Modulim
When was Modulim founded?
Modulim was founded in 2002 and raised its 1st funding round 4 years after it was founded.
Where is Modulim located?
Modulim is headquartered in Irvine, United States. It is registered at Irvine, California, United States.
Who is the current CEO of Modulim?
Amaan Mazhar is the current CEO of Modulim.
Is Modulim a funded company?
Modulim is a funded company, having raised a total of $12.36M across 16 funding rounds to date. The company's 1st funding round was a Series A of $2.86M, raised on Sep 19, 2006.
What does Modulim do?
Modulim provides the non-invasive imaging devices for detection of diabetic foot ulcer. It measuring microvascular tissue oxygenation and hemoglobin concentration by Spatial Frequency Domain Imaging technique for detection. Its flagship product is Clarifi which is non-contact device that measures critical hemoglobin biomarkers in tissue.
Who are the top competitors of Modulim?
Modulim's top competitors include Mimosa Diagnostics, O’Brien Medical and OxiLight.
What products or services does Modulim offer?
Modulim offers Imaging Solutions and Data Solutions.
Who are Modulim's investors?
Modulim has 10 investors. Key investors include NIH, Fresenius Medical Care, HHS, Hamamatsu Photonics, and Pangaea Ventures.